Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Kendle | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Kendle

Service revenues are down, but new business awards jumped from 1Q10.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kendle 2Q10

2Q Service Revenues*: $82.4 million (-23%)

2Q Earnings: $1.9 million (-40%)

YTD Service Revenues*: $173 million (-20%)

YTD Earnings: $3.1 million (-24%)

Comments: Kendle’s top five customers based on net service revenues accounted for 25% of total revenues versus 28% in 2Q09. New business awards for the 2Q10 were $131.5 million, up 48% from 1Q10. Contract cancellations and other adjustments added up to $30.9 million, 4% of the company’s backlog, so net book-to-bill was 1.2. New business authorizations (backlog) were $778.0 million as of June 30, 2010.

* Kendle must count reimbursable out-of-pocket revenues as part of total revenues. These were $29 million in 2Q10 (-17%) and $55 million for 1H10 (-23%), and are offset in the company’s costs and expenses.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters